|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
AGY Therapeutics Inc., of South San Francisco, began drug discovery programs for two ischemic stroke drug targets, AGY-203 and AGY-207. The proteins belong to different druggable classes of intracellular enzymes, but their involvement in stroke was previously unknown. AGY identified and validated the candidates with its imagine research platform, and expects to produce small-molecule drug candidates in the second half of this year.
AnVil Informatics Inc., of Burlington, Mass., said it formed a pilot project with Genomics Collaborative Inc., of Cambridge, Mass., to apply AnVilEs analysis and visualization knowledge and tools to GCIEs DNA microarray data. The ...